PT Darya-Varia Laboratoria Tbk (IDX:DVLA)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
1,650.00
-20.00 (-1.20%)
Aug 8, 2025, 2:00 PM WIB
-1.20%
Market Cap1.87T
Revenue (ttm)2.09T
Net Income (ttm)158.23B
Shares Out1.12B
EPS (ttm)141.28
PE Ratio11.82
Forward PEn/a
Dividend110.00 (6.51%)
Ex-Dividend DateJun 30, 2025
Volume3,700
Average Volume40,375
Open1,670.00
Previous Close1,670.00
Day's Range1,650.00 - 1,675.00
52-Week Range1,325.00 - 1,850.00
Beta-0.22
RSI48.91
Earnings DateJul 28, 2025

About IDX:DVLA

PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company offers prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women healthcare, antiparasit, vitamin and food supplements, anti fungal, plastic surgery, general surgery, burn, trauma wound, aesthetic medicine, somatik, ear... [Read more]

Sector Healthcare
Founded 1976
Employees 1,270
Stock Exchange Indonesia Stock Exchange
Ticker Symbol DVLA
Full Company Profile

Financial Performance

In 2024, IDX:DVLA's revenue was 2.09 trillion, an increase of 10.40% compared to the previous year's 1.89 trillion. Earnings were 156.15 billion, an increase of 6.70%.

Financial Statements

News

There is no news available yet.